CURRICULUM VITAE
Stuart J. Wong MD
Stuart J. Wong MD
Center Director, Professor
Department of Medicine
Division of Hematology and Oncology - Medicine
Department of Medicine
Division of Hematology and Oncology - Medicine
OFFICE ADDRESS: |
Froedtert Hospital |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
EDUCATION: |
09/1981 - 06/1985 AB - Mathematics, Occidental College, Los Angeles, CA |
09/1983 - 06/1984 Junior Year Abroad Program, University of Sussex, Sussex, England |
08/1986 - 05/1990 MD, Medical College of Wisconsin, Milwaukee, WI |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
07/1990 - 06/1993 Resident, Internal Medicine |
07/1994 - 06/1998 Hematology Oncology Fellow, Hematology/Oncology |
01/2000 - 12/2001 Clinical Investigator, K30 Clinical Research Scholar Program |
FACULTY APPOINTMENTS: |
07/1993 - 06/1994 Clinical Instructor, Medicine, General Internal Medicine, Medical College of Wisconsin, Milwaukee, WI |
07/1998 - 06/2007 Assistant Professor, Medicine, Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI |
07/2007 - 06/2015 Associate Professor, Medicine, Neoplastic Diseases, Medical College of Wisconsin, Milwaukee, WI |
07/2011 - 06/2015 Associate Professor, Otolaryngology, Medical College of Wisconsin, Milwaukee, WI |
07/2015 - Present Professor, Hematology Oncology and Otolaryngology, Medical College of Wisconsin, Milwaukee, WI |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
07/1998 - 2002 Director, Hematology Oncology Core Curriculum, Medical College of Wisconsin, Milwaukee, WI |
2014 - Present Program leader, Head and Neck Cancer Disease Oriented Team, Medical College of Wisconsin, Milwaukee, WI |
2019 - 2021 Co-Director, Center for Disease Prevention Research, Medical College of Wisconsin, Milwaukee, WI |
11/2021 - 09/2022 Interim Associate Chief, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI |
2021 - Present Director, Center for Disease Prevention Research, Medical College of Wisconsin, Milwaukee, WI |
04/2028 - Present Chair, MCW Cancer Center Investigator Initiated Trial Steering Committee, Medical College of Wisconsin, Milwaukee, WI |
HOSPITAL STAFF PRIVILEGES: |
1993 - Present Hematology Oncology, Medicine, Froedtert Memorial Lutheran Hospital, Milwaukee, WI |
1993 - Present Zablocki Veterans Affairs Medical Center, 5000 W. National Ave., Milwaukee, WI 53295 |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
Internal Medicine | 1993 | 2003 |
Medical Oncology | 1998 | 2028 |
Licensure | Number | Issue Date | Expiration |
Wisconsin License | 33593 | 1991 | 2025 |
AWARDS AND HONORS: |
2008 RTOG Next Generation Investigator Award , Radiation Therapy Oncology Group, 40th Anniversary Celebration |
2011 MCW Outstanding Faculty Service Award, Medical College of Wisconsin |
2011 - 2017 U.S. News and World Report, Best Doctors |
2013 M Magazine Top-Rated Doctors |
2019 Medical College of Wisconsin Eminent Scholar |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
1983 - 1984 National Mathematics Honor Society (Pi Mu Epsilon) |
1991 - Present Wisconsin State Medical Society (Member ) |
1998 - Present Eastern Cooperative Oncology Group (ECOG)
•Head and Neck Cancer Committee |
1999 - Present NRG Oncology (Radiation Therapy Oncology Group-RTOG)
• Head and Neck Cancer Committee
• Medical Oncology Committee
• Translational Research Program
• Gastrointestinal Cancer Committee |
1999 - Present American Society of Clinical Oncology (Member ) |
2001 - Present American Society for Therapeutic Radiation and Oncology (Member) |
2003 - Present International Transplant Skin Cancer Collaborative (ITSCC) |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Editorial Board |
2001 - 2008 MCW Healthlink |
2006 - 2010 Journal of Clinical Oncology |
Journal Review |
Journal of Palliative Medicine, RTOG Publications Committee, UpToDate, Cancer |
Journal of Personalized Medicine, International Journal of Radiation Oncology Biology Physics, Head & Neck, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Annals of Oncology |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
02/2003 - Present Lead Investigator, University of Chicago Phase II Consortium, National Cancer Institute |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
01/2004 - 01/2007 Chair RTOG Translational Research Program (TRP), Head and Neck Cancer Subcommittee, NRG Oncology (Radiation Therapy Oncology Group--RTOG), National Cancer Institute, Cooperation Group |
12/2004 - 01/2009 RTOG Nominating Committee, NRG Oncology (Radiation Therapy Oncology Group--RTOG), National Cancer Institute, Cooperation Group |
07/2005 - 2010 Advisory Committee member, Longitudinal Registry of Head and Neck Cancer (LORHAN) |
07/2006 - 03/2014 Head and Neck Co-Chair, RTOG Medical Oncology Committee, NRG Oncology (Radiation Therapy Oncology Group--RTOG), National Cancer Institute, Cooperation Group |
07/2006 - Present Co-Chair, NRG Oncology Head and Neck Cancer Committee, NRG Oncology (Radiation Therapy Oncology Group--RTOG), National Cancer Institute, Cooperation Group |
07/2006 - 06/2007 Chairperson, Scientific Program Committee, Head and Neck Cancer, American Society of Clinical Oncology (ASCO) |
2007 - Present Metastatic/Recurrent Disease Task Force, NCI Head and Neck Cancer Steering Committee, National Institutes of Health, National Cancer Institute (NCI) |
06/2012 - 2014 Cancer Prevention Committee, American Society of Clinical Oncology (ASCO) |
2014 - Present NCI Head and Neck Cancer Steering Committee, National Institutes of Health, National Cancer Institute (NCI) |
2015 - 2016 Member, 9th Annual International Conference on Head and Neck Cancer Scientific Review Committee, American Head and Neck Society |
2017 - 2020 NCI Cancer Prevention and Control Central Institution Review Board, National Institutes of Health, National Cancer Institute (NCI) |
2019 - Present RTOG Foundation Board, NRG Oncology (Radiation Therapy Oncology Group--RTOG), National Cancer Institute, Cooperation Group |
07/2020 - Present Board Member, Head and Neck Cancer Alliance |
2021 - Present Secretary, RTOG Foundation Board, NRG Oncology (Radiation Therapy Oncology Group--RTOG), National Cancer Institute, Cooperation Group |
07/2025 - 06/2026 Scientific Program Committee, Head and Neck Cancer, American Society of Clinical Oncology (ASCO) |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
Ribonucleotide Reductase: A Target for Gemcitabine-Mediated Radiosensitization, Radiation Therapy Oncology Group (RTOG), Scientific Session, Lung Cancer Committee, Montreal, Canada, 06/2000 |
Capecitabine for Transplant Associated Skin Cancer, International Transplant Skin Cancer Collaborative (ITSCC), Annual Meeting, San Francisco, CA, 03/2003 |
Capecitabine for Non Melanoma Skin Cancer in Organ Transplant Recipients, Skin Cancer in Organ Transplant Patients Europe (SCOP), Annual meeting, University of Lyon, Lyon, France, 08/2004 |
New Developments in Locally Advanced Head and Neck Cancer, RTOG Semi-Annual Meeting, Research Associate Scientific Session, Toronto, Canada, 06/2006 |
Preoperative chemotherapy treatment in stage II - III: Monotherapy vs Combined therapy, XVI International Symposium advances in Treatment of Digestive Tumors, Malaga, Spain, 12/2009 |
National |
LY-1 B Cells in NZ B x W Mice, Children’s Hospital of Los Angeles, 08/1987 |
New Developments in Combined Modality Therapy in Non Small Cell Lung Cancer, Marquette, MD, 03/2000 |
New Developments in Non Small Cell Cancer Treatment, Medical Grand Rounds, Marquette General Hospital/Televised Marquette Health Care Network, 03/2000 |
New Developments in Medical Neoplasia, Alumni Day Lecture, Medical College of Wisconsin, 05/2003 |
ASCO 2004 Update: Head and Neck Cancer, RTOG Semi-Annual Meeting, Washington, DC, 06/2004 |
Radiation-Associated Oral Mucositis in Head and Neck Cancer, Radiation Oncology Department Grand Rounds, 10/2004 |
Radiation-Associated Oral Mucositis in Head and Neck Cancer, University of Chicago, Head and Neck Conference Grand Rounds, 11/2004 |
Abstracts 5500, 5501: Management of the Elderly Head and Neck Cancer Patient, 2006 Proceedings of American Society of Clinical Oncology (ASCO); Discussant, Head and Neck Oral Session, Atlanta, GA, 06/2006 |
Concurrent Chemotherapy and Radiation for Salivary Carcinomas, National Cancer Institute; Salivary Malignancy Workshop, Bethesda, MD, 11/2006 |
Concurrent Radiochemotherapy for Local Relapse or Second Primary, American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting, Philadelphia, PA; Presidential Course: Biology and Therapy of Head and Neck Carcinoma, 11/2006 |
Best of ASCO 2007: Head and Neck Cancer, 2007 Best of ASCO West Meeting, San Francisco, CA, 07/2007 |
RTOG 0247: A Randomized Phase II Study Of Neoadjuvant Capecitabine And Irinotecan Versus Capecitabine And Oxaliplatin With Concurrent Radiation Therapy For Locally Advanced Rectal, RTOG Semi-Annual Meeting, Philadelphia, PA, 06/2008 |
Local Regional Recurrent Disease, 2008 American Head and Neck Society Annual Meeting, San Francisco, CA, 07/2008 |
Systemic Chemotherapy for Nasopharyngeal Carcinoma, American Head and Neck Society Annual Meeting, San Francisco, CA, 07/2008 |
Use of Novel Therapies in RTOG Studies, American Head and Neck Society's 2010 Research Workshop on the Biology, Prevention & Treatment of Head & Neck Cancer, Arlington, VA, 10/2010 |
A Phase II Study of Dasatinib (BMS 354825) in Recurrent or Metastatic ckit-Expressing Adenoid Cystic (ACC) and Non-ACC Malignant Salivary Glands Tumors (MSGT) --- NCI 8271, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 06/2013 - Present |
Regional |
Re-Irradiation for Recurrent Head and Neck Cancer, Scientific Symposium, Southwestern Oncology Group Semi-Annual Meeting, Head and Neck Subcommittee, Kansas City, 10/2004 |
Site Visit, Eastern Cooperative Oncology Group, Site Audit, University of Minnesota, 11/2005 |
Re-Irradiation: Never Say Never Again, 2007 Annual American Society of Clinical Oncology Meeting, Chicago, IL, 06/2007 |
Integrating Intensity Modulated Radiation Therapy/Image-Guided Radiation Therapy and Systemic Chemotherapy Into a Combined Modality Therapeutic Strategy, 2008 Annual American Society of Clinical Oncology Meeting, Chicago, IL, 06/2008 |
Head and Neck Cancer, Poster Discussion, 2008 Annual American Society of Clinical Oncology Meeting, Chicago, IL, 06/2008 |
Discussant , Poster Discussion Session, Head and Neck Cancer, 2009 Annual American Society of Clinical Oncology Meeting, Chicago, IL, 06/2009 |
Local |
Ventricular Septal Rupture Following Myocardial Infarction, St. Joseph’s Hospital, Milwaukee, WI, 12/1991 |
The CBC, Nurse Practitioners Association of Milwaukee, Milwaukee, WI, 11/1994 |
New Developments in Locally Advanced Head and Neck Cancer, Oncology Pharmacists Meeting, Southeast Wisconsin, 04/2006 |
Use of Monoclonal Antibodies for Treatment of Solid Tumor Malignancies, Alumni Symposium for Senior Physicians, Medical College of Wisconsin, Milwaukee, WI, 10/2006 |
"Clinical Oncology Research at MCW---A Medical Oncology Perspective", MCW Division of Biostatistics, Statistical Seminar Series,, Milwaukee, WI, 04/2013 - Present |
COMMITTEE SERVICE: |
Medical College of Wisconsin |
07/1998 - Present Member, Pharmacy Nutrition and Therapy (PNT)Committee, Medical College of Wisconsin |
07/1998 - 05/2005 Member, Residency Review Committee, Medical College of Wisconsin |
07/2000 - Present Member, Neoplastic Diseases Fellowship Committee, Medical College of Wisconsin |
01/2001 - 2003 Member, PNT Medication Error Committee, Medical College of Wisconsin |
01/2002 - 2003 Co-chair, MCW Cancer Center Scientific Review Committee, Medical College of Wisconsin |
2007 - 2008 Member, Epic Implementation Team, Neoplastic Diseases, Medical College of Wisconsin |
2008 - 2011 Member, Nominating Committee, Faculty Council, Medical College of Wisconsin |
2009 - Present Member, Advisory Committee, IRB, Medical College of Wisconsin |
2009 - 2011 Member, IRB Committee #4, Medical College of Wisconsin |
2010 - Present Chairman, PNT Cancer Subcommittee, Medical College of Wisconsin |
2010 - Present Member, Innovations Task Force on Mentoring, Office of Research, Medical College of Wisconsin |
2010 - Present Chairman, Skin Cancer Research Fund, Medical College of Wisconsin |
2012 - Present Co-Chair, MCW Research Day Committee |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
01/2000 “Introduction to Medical Oncology” Medical College of Wisconsin, M2 Pathology Lecture |
09/2003 “Introduction to Medical Oncology” Medical College of Wisconsin, M2 Pathology Lecture |
“Lung Cancer” Junior Medical Students Core Curriculum |
Resident and Fellow Education |
02/1993 “Disseminated Intravascular Coagulation”, Med Path Conference |
07/1995 “Ribonucleotide Reductase” Division of Hematology/Oncology Fellows Conference |
10/1995 “Acute Myelogenous Leukemia” Internal Medicine Resident Conference |
10/1995 “Carboplatin Dosing”, Division of Hematology/Oncology Fellows Conference |
02/1996 “T-Cell Activation and Tyrosine Phosphorylation” Division of Hematology/Oncology Fellows Conference |
07/1998 - 2002 Director, Hematology Oncology Core Curriculum |
01/1999 “Clinical Pathology Conference” (CPC), Department of Medicine, Zablocki VA Medical Center |
04/2002 “Are We There Yet: Organ Preservation for Head and Neck Cancer”, Otolaryngology |
12/2002 “Hypercalcemia of Malignancy”, Internal Medicine Resident Noon Conference |
01/2004 “Management of Head and Neck Cancer” Internal Medicine Resident Noon Conference |
06/2004 “Management of Head and Neck Cancer: Medical Oncology Perspective” Otolaryngology |
08/2005 “Chemotherapy for Head and Neck Cancer”, Radiation Oncology Resident Lecture Series |
06/2006 “New Developments in Locally Advanced Head and Neck Cancer”, Otolaryngology |
07/2006 - Present Tuesday Hematology Oncology Fellow Clinic |
12/2007 “Head and Neck Cancer Update: Medical Oncology Perspective”, Radiation Oncology Resident Teaching Conference |
04/2009 “Rectal and Anal Cancer Update: Medical Oncology Perspective”, Radiation Oncology Resident Teaching Conference |
05/2009 “Diagnosis and Management of Malignant Melanoma” Internal Medicine Resident Academic Half Day Lecture |
05/2010 “Diagnosis and Management of Malignant Melanoma” Internal Medicine Resident Academic Half Day Lecture |
01/2011 “Novel Therapies in RTOG Studies” |
Community/Lay Public |
10/2002 A New Oral Chemotherapy Drug for Rectal Cancer”, Channel 6 Morning Wake-Up News |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Wong, S.J. , Meropol, N.J, Winter, K., Anne, R., Kachnic, L, Rashid, A. Watson, J.C. Mitchell, E. Pollock, J. Lee, R.J., Haddock, M., Erickson, B., Willett, C. RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Locally Advanced Rectal Cancer. J. Clin. Oncol (Submitted, J Clin Oncol) |
2. Leena, M. V., Michel, M.A., Firat, S., Loerhl T., Loehrl T., Wong, S. J. Paranasal Small Cell Carcinoma Associated with Methylenetetrahydrofolate Reductase Gene Mutation. |
3. Davis, D.W., Seiwert, T.Y., Karrison T. G., Yan, D., Liu, W., McConkey, D.J., Pierce, C., Martin, L.E., Nichols, K., Wong, S.J. , Dancey, J.E. , Stenson, K, Blair, E., Dekker, A, Vokes, E.E., Cohen, E.E.W., Vascular Endothelial Growth Factor and Endothelial Cell Epidermal Growth Factor Receptor Activation Predicts Response to Bevacizumab and Erlotinib in Recurrent or Metastatic Head and Neck Cancer (Submitted, J Clin Oncol) |
4. Wong S.J., Myette MS, Wereley JP, and Chitambar CR. Increased sensitivity of Hydroxyurea-resistant leukemic cells to gemcitabine. Clinical Cancer Research 5(2):439-43, 1999. |
5. Green D.A., Antholine W.E., Wong S.J., Richardson, D.E., Chitambar, C.R. Inhibition of Malignant Cell Growth, by 311, a Novel Iron Chelator of the Pyridoxal, Isonicotinyl Hydrazone Class: Effect on the R2 subunit of Ribonucleotide Reductase, Clin Cancer Res. 2001 Nov;7(11):3574-9. |
6. Hacein-Bey L, Baisden JL, Lemke DM, Wong SJ, Ulmer JL, Cusick JF. Treating osteoporotic and neoplastic vertebral compression fractures with vertebroplasty and kyphoplasty Palliat Med. 2005 Oct;8(5):931-8. |
7. Ozcan C, Wong SJ, Hari P. Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab. N Engl J Med. 2006 Mar 2;354(9):980-2; discussion 980-2. |
8. Wong, S. J. Machtay, M., Yi Li "Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Reirradiation and Chemotherapy or Chemotherapy Alone?", J Clin Oncol. 2006 Jun 10;24(17):2653-8. |
9. A. Argiris, E. Cohen, T. Karrison, B. Esparaz, A. Mauer, R. Ansari, S. Wong, Y. Lu, M. Pins, J. Dancey, E. Vokes. A Phase II Trial Of Perifosine, An Oral AKT Inhibitor, In Recurrent Or Metastatic Head And Neck Cancer, Cancer Biol Ther. 2006 Jul 2;5(7) |
10. Wang D, Schultz CJ, Jursinic PA, Bialkowski M, Zhu XR, Brown WD, Rand SD, Michel MA, Campbell BH, Wong S, Li XA, Wilson JF. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):143-51 |
11. Edmonson, D.A., Gruling, B.J., Urmanski, A.M., Wong, S.J., Levy, M.B., Oxaliplatin Hypersensitivity: Case Report and Successful Repeat Desensitization, Am J Ther. 2007 Jan-Feb;14(1):116-8. |
12. Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S., Ang K. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007 Oct 20; 25 (30):4800-5. |
13. Vernon, M.R., Maheshwari, M., Schultz, C.J., Michel, M.A., Wong, S.J., Campbell, B.H., Massey, B.L., Wilson, J.F., Wang, D. Clinical Outcomes Of Patients Receiving Integrated PET/CT guided Radiotherapy For Head And Neck Carcinoma, Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):678-84. |
14. Wong, S.J., Spencer, S. Reirradiation and Concurrent Chemotherapy After Salvage Surgery: Pay Now or Pay Later, J. Clin Oncol. 2008 Dec. 1 26 (34):5500-5501 |
15. Cohen, E.E.W, Davis, D.W, Karrison T.G., Seiwert T.Y., Wong, S.J., Nattam, S., Kozloff, M.F., Clark, J.I., Yan, D., Liu, W, Pierce, C, Dancey, J.E., Stenson, K., Blair, E., Dekker, A., Vokes, E.E. Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study, The Lancet Oncology, Volume 10, Issue 3, 247 - 257, March 2009 |
16. Murphy BA, Chen A, Curran WJ Jr, Garden AS, Harari PM, Wong SJ, Ang KK. Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings. Support Care Cancer. 2009 Nov;17(11):1393-401. Epub 2009 Mar 5. |
17. Wong, S.J., Harari, P.M., Garden, A.S., Schwartz, M., Bellm L., Chen, A., Curran, W.J., Murphy, B.A., and Ang, K.K. Longitudinal Oncology Registry Of Head And Neck Carcinoma: Analysis of Chemoradiation Treatment Approaches in the United States", Cancer. 2011 Apr 15;117(8):1679-86. doi: 10.1002/cncr.25721. |
18. Sun, A., Bae, K, Gore, E. M., Movsas, B., Wong, S.J., Meyers, C.A, Bonner J. A, Schild S. E., Gaspar, L.E., Bogart, J.A., Werner-Wasik, M., and Choy, H. A phase III comparison of prophylactic cranial irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer: Neurocognitive and quality of life analysis of Radiation Therapy Oncology Group 0214. J Clin Oncol. 2011 Jan 20;29(3):279-86. |
19. Gore, E. M., Bae, K, Wong, S.J., Sun, A., Movsas, B., , Meyers, C.A, Bonner J. A, Schild S. E., Gaspar, L.E., Bogart, J.A., Werner-Wasik, M., and Choy, H. A phase III comparison of prophylactic cranial irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer: Primary analysis of Radiation Therapy Oncology Group (RTOG) 0214. J Clin Oncol, J Clin Oncol. 2011 Jan 20;29(3):272-8. |
20. Zundel MT, Michel MA, Schultz CJ, Maheshwari M, Wong SJ, Campbell BH, Massey BL, Blumin J, Wilson JF, Wang D. Comparison of Physical Examination and Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 4-6 Months After Radiotherapy to Assess Residual Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys. 2011 Feb 5. |
21. Jordan Kharofa, Nicholas Choong, Dian Wang, Selim Firat, Christopher Schultz, Chitra Sadasiwan, Stuart Wong. Continuous Course Re-irradiation with Concurrent Carboplatin and Paclitaxel for Locally Recurrent, Non-metastatic Squamous Cell Carcinoma of the Head and Neck. Int.J.Radiat. Biol Phys. Provisionally accepted. |
22. Kiran Devisetty, M.D., Stuart J. Wong, M.D., Loren K. Mell, M.D. How does TPF improve survival over PF? Lancet Oncology, In Press. |
23. Wong, S.J. , Meropol, N.J, Winter, K., Anne, R., Kachnic, L, Rashid, A. Watson, J.C. Mitchell, E. Pollock, J. Lee, R.J., Haddock, M., Erickson, B., Willett, C. RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Locally Advanced Rectal Cancer. Int.J.Radiat. Biol Phys. In Press. |
24. Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, Anderson AM, Ekpenyong A, Rupji M, Abousaud M, Rudra S, Bates JE, Remick JS, Joshi NP, Woody NM, Awan M, Geiger JL, Shreenivas A, Samsa J, Ward MC, Schmitt NC, Patel MR, Higgins KA, Teng Y, Steuer CE, Shin DM, Liu Y, Ahmed R, Koyfman SA. Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01;10(7):896-904. PMCID: PMC11117153 |
Books, Chapters, and Reviews |
1. Gore EM, Wong, S.J.: Stage IIE Non Hodgkin's Lymphoma of the Oropharynx (book chapter) Winchester D(ed): Tumor Board Case Management, New York, NY Lippincott, 1997. |
2. Jhala N, Siegal G.P., Wong S.J., Hackbarth D., Shidham V.B. Telangiectatic Osteosarcoma, In Orthopedic Surgery. Ed. Chansky HA, Talavera F, Anderson G, Keenan MAE.. eMedicine Journal, August 22 2001, Volume 2, Number 8. Book chapter. |
3. Rao N, Wong S, Hackbarth DA, Panikkar V, Shidham VB: Postradiation Sarcoma, In Orthopedic Surgery. Ed. Chansky HA, Talavera F, Anderson G, Keenan MAE.. eMedicine Journal, August 22 2001, Volume 2, Number 8. Book chapter. |
Non-Refereed Journal Publications/Original Papers |
1. Wong, S.J., Schultz C.J. Re-Irradiation: Never Say Never Again, American Society of Clinical Oncology Educational Book, 43rd Annual Meeting, Spring 2007, p 339 |
2. Chung C.H., , Wong S. J., , Ang K.K., Hammond E.H., Dicker A.P.,Harari P.M., Le, Q.T. Strategic plans to promote head and neck cancer translational research within Radiation Therapy Oncology Group: A report from the Translational Research Program. International Journal of Radiation Oncology Biology Physics. 2007, .69 (2),S67-S78. |
3. Wong S. J. American Society of Clinical Oncology 2007 Annual Meeting Summaries, Oral Abstract Presentations and Plenary Session from the 43rd Annual Meeting, Head and Neck Cancer. 2007, p109-114. |
Abstracts |
1. Wong S. J., Wereley J, Chitambar CR: Ribonucleotide reductase expression and iron transport in mitogen activate human T-lymphocytes: relationship to iron transport, transferrin receptor, ferritin, and DNA synthesis. Blood: 124b, 1996. |
2. Wong S.J., Myette MS, Wereley JP, Chitambar CR: Supersensitivity to gemcitabine in hydroxyurea-resistant human leukemic CCRF-CEM cells. Presented at the 89th annual meeting of the American Association for Cancer Research New Orleans, LA. March 1999. |
3. Chang C.C., Revolinski JP, Purpi D., Chitambar CR, Wong S.J. Measurement of Ribonucleotide Reductase R2 Subunit Expression by One-Step Multiplex Real-Time Quantitative RT-PCR. Proceedings of the American Association from Cancer Research 93rd Annual Meeting. |
4. Wong S.J., Chang C.C., Revolinski JP, Chitambar C.R. Radiosensitizing Effects of Gallium Are Modulated by Expression of R2 Subunit of Ribonucleotide Reductase. Proceedings of the American Association from Cancer Research 93rd Annual Meeting. |
5. Hacein-Bey, L, Baisden, J., Wong, S.J., Lemke, D, Henry, M, Ulmer J.L., Cusick, J.F., Treating Osteoporotic and Neoplastic Vertebral Compression Fractures with Vertebroplasty and Kyphoplasty. |
6. S. J. Wong, C. Sadasiwan, B. Erickson, D. Ota, D. Mulkerin, J. Thomas, K. Holen, S. Meadows, P. Ritch, G. Telford, P. Redlich, E. Gore. "A Phase II Trial Of Pre-Operative Capecitabine And Concurrent Radiation For Locally Advanced Rectal Cancer", Abstract, 2004 Gastrointestinal Cancers Symposium, San Francisco, Jan, 2004 |
7. M. Mauer, E. E. W. Cohen, S. J. Wong, M. Kozloff, J. Winegarden, D. M. Gustin, E. E. Vokes. Phase I study of epidermal growth factor receptor (EGFR) inhibitor, erlotinib, and vascular endothelial growth factor monoclonal antibody, bevacizumab, in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). 2004 Proceedings of American Society of Clinical Oncology. |
8. CJ. Langer, J. Harris, E. Horwitz, N. Nicolaou, M. Kies, W. Curran, S. Wong, K. K. Ang. Phase II trial of concurrent split course hyperfractionated radiotherapy (Hfx RT), cisplatin (DDP) and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN): Results of RTOG 9911. 2004 Proceeding of American Society of Clinical Oncology Abstract #5509 |
9. S. J. Wong, C. Sadasiwan, B. Erickson, D. Ota, D. Mulkerin, J. Thomas, K. Holen, S. Meadows, G. Telford, E. Gore. "A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer. 2004 Proceedings of American Society of Clinical Oncology. |
10. Sadasiwan, C, Schultz, C, Firat, S, Campbell, B, Wong, S. Continuous Course Reirradiation With Concurrent Weekly Chemotherapy For Patients With Unresectable Recurrent Head And Neck Cancer. 2004 Malignancies of the Chest & Head and Neck, Lung Cancer 2004; 46: S80. |
11. A. Argiris, E.E.W. Cohen, J.Wade, A. Mauer, D.Gustin, R. Ansari, S. Wong, T. Karrison, E.E. Vokes. A Phase II Trial of Perifosine in Patients with Recurrent or Metastatic Head and Neck Cancer. 2004 Malignancies of the Chest & Head and Neck, Lung Cancer 2004; 46: S66. |
12. E. E. Vokes, E. E. Cohen, A. M. Mauer, T. G. Karrison, S. J. Wong, L. J. Skoog-Sluman, M. F. Kozloff, J. Dancey, A. Dekker, A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC) 2005 Proceeding of American Society of Clinical Oncology Abstract #5504 |
13. E. M. Horwitz, J. Harris, C. J. Langer, N. Nicolaou, M. Kies, W. Curran, S. J. Wong, K. Ang. Concurrent Split Course Hyperfractionated Radiotherapy (Hfx RT), Cisplatin (DDP) and Paclitaxel (P) in Patients with Recurrent, Previously Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN): Update of RTOG 9911. 2005 Proceeding of American Society of Clinical Oncology Abstract #5577 |
14. S. M. Smith, B. Pro, K. van Besien, K. Conner, T. Karrison, S. Wong, P. Stiff, E. Vokes. A Phase II Study of Epothilone B analog BMS-247550 (NSC 710428) in Patients with Relapsed Aggressive non-Hodgkin's lymphomas. 2005 Proceedings of American Society of Clinical Oncology Abstract #6625 |
15. S. J. Wong, Z. Agha, S. Milligan. Concurrent chemotherapy practice patterns for head and neck cancer: what is standard of care? 2005 Proceedings of American Society of Clinical Oncology, Abstract |
16. Curran W., Chen A, Harari, P, Murphy B, Wong, S., Bellm, L , Gamber, D., Dawson D. , and Ang, K.. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN), a new national cancer registry, 2006 Proceedings of American Society of Clinical Oncology Abstract |
17. Abidoye, O., Cohen, E.E.W., Wong, S., Kozloff, M., Stenson, K., Blair, E, Day, S. , Dancey, J., Vokes, E.E.. A Phase II Study of GW572016 in Recurrent/Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN), 2006 Proceedings of American Society of Clinical Oncology, Vol 24, No. 18S (June 20 Supplement), 2006 |
18. S. J. Wong, Z. Agha, S. Milligan. Concurrent chemotherapy practice patterns for head and neck cancer: What is standard of care? Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 5542 |
19. Chen,A., Curran, W. , Harari, P., Murphy, B., Wong, S, Bellm, L. , Gamber, D, Dawson, D., and Ang, K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN), a new national cancer registry, 2006 American Head and Neck Society Meeting |
20. Wong, S, Machtay, M. , Langer, C, Schultz, C., Ridge J.A., List, M, Konski, A, Pajak, T.F., Ang, K. RTOG 0421, A Phase III Trial For Recurrent, Previously Irradiated Head and Neck Cancer: Re-RT and CT vs CT Alone, 2006 American Head and Neck Society Meeting |
21. T. Y. Seiwert, D. W. Davis, D. Yan, A. M. Mauer, T. Karrison, M. Kozloff, A. Dekker, S. J. Wong, E. E. Vokes, E. E. Cohen pKDR/KDR ratio predicts response in a phase I/II pharmacodynamic study of erlotinib and bevacizumab for recurrent or metastatic head and neck cancer (HNC). 2007 Proceedings of American Society of Clinical Oncology. |
22. Wong, S.J., Winter, K., Meropol, N.J., Anne, R., Kachnic, L.A., Rashid, A., Watson, J.C., Mitchell, E.P., Pollock, J., R. J., Lee, Willett, C. G. RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal, 2008 Proceedings of American Society of Clinical Oncology, J Clin Oncol 26: 2008 (May 20 suppl; abstr 4021) |
23. Cohen, E.E., Needles, B.M., Cullen, K.J., Wong, S.J., Wade, J.L., Ivy, S.P., , Villaflor, V.M., Seiwert, T.Y., Nichols, K., Vokes, E.E., Phase 2 study of sunitinib in refractory thyroid cancer, 2008 Proceedings of American Society of Clinical Oncology , J Clin Oncol 26: 2008 (May 20 suppl; abstr 6025) |
24. Curran, W.J. , Chen, A. , Garden, A. , Harari, P. , Murphy, B. A., Wong, S. J., Bellm, L., Schwartz, M., Dawson, D. , Ang, K., Longitudinal oncology registry of head and neck carcinoma (LORHAN): Initial treatment findings. 2008 Proceedings of American Society of Clinical Oncology, J Clin Oncol 26: 2008 (May 20 suppl; abstr 6054) |
25. E. Gore, K. Bae, S. Wong, J. Bonner, A. Sun, S. Schild, L. Gaspar, J.Bogart, M. Werner-Wasik, H. Choy. Initial analysis of RTOG 0214: A phase III comparison of prophylactic cranial irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer (LA-NSCLC). Submitted to 2009 Proceedings of American Society of Clinical Oncology |
26. K. K. Ang, W. J. Curran, A. Chen, A. S. Garden, P. Harari, B.A. Murphy, S. Wong, L. Bellm, M. Schwartz, D. Dawson Longitudinal oncology registry of head and neck carcinoma (LORHAN): first report of outcomes. Submitted to 2009 Proceedings of American Society of Clinical Oncology. |
27. Daniel E. Cannon, Sunitha Sukumaran, Stuart Wong, Nicholas Choong, Becky L. Massey. Effect of Pre-treatment BMI on Feeding Tube Use and Dependence in Head and Neck Cancer Patients Undergoing Chemoradiation, Combined Otolaryngology Spring Meetings, April 2010 (abstract) |
28. Wong, S., J., Campbell, B., Massey, B., Lynch, D., Cohen, E.E.W., Jovanovic, B.D., Bergan, R.C. A Phase I Trial of ALA PDT For Treatment of Oral Leukoplakia, 2009 NCI Translational meeting, November 2009. |
29. Brinkerhoff, B., Campbell, B., Tripp, P., Wong, S., Choong, N. Treatment Delay in Advanced-stage Head and Neck Cancer Patients Treated with Concurrent Chemoradiotherapy, Multidisciplinary Head & Neck Cancer Symposium , Feb, 2010. |
30. Wong, S., J., Campbell, B., Massey, B., Lynch, D., Cohen, E.E.W., Jovanovic, B.D., Bergan, R.C. A Phase I Trial of ALA PDT For Treatment of Oral Leukoplakia, Multidisciplinary Head & Neck Cancer Symposium , Feb, 2010. |
31. Chen, A., Curran, W.J., Garden, A. S., Harari, P.M., Murphy, B.A., Wong,S.J., Bellm, L., Schwartz, M., and Ang, K.K. Longitudinal oncology registry of head and neck carcinoma (LORHAN): socioeconomic and supportive care findings, 2010 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting |
32. Harari, P.M., Chen, A., Curran, W.J., Garden, A. S., Murphy, B.A., Wong,S.J., Bellm, L., Schwartz, M., and Ang, K.K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN®): Overview of Data Set, 2010 Proceedings of American Society of Clinical Oncology. |
33. Wong,S.J., Chen, A., Curran, W.J., Garden, A. S., Harari, P.M., Murphy, B.A., , Bellm, L., Schwartz, M., and Ang, K.K. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Findings Related to the Oropharynx. 2010 Proceedings of American Society of Clinical Oncology. |
34. B.A. Murphy, A. Chen, W. J. Curran, A. S. Garden, P. Harari, S. Wong, L. Bellm, M. Schwartz, J. Newman, D. Adkins, N. Hayes, U. Parvathaneni, D. Brachman, B. Ghabach, M. Guarino, M. Greenberg, A. Abitbol, P.R. Anné, and K. K. Ang. Longitudinal oncology registry of head and neck carcinoma (LORHAN): analysis of disparities in care. Annual Meeting, ASTRO 2011 |
35. M. DeMara, N. Duncan, S. Wong, M. Neuburg, Z. Lazarova and E B Olasz Expression of epidermal growth factor receptor (EGFR) and detection of mutant EGFR (EGFRvIII) in human cutaneous squamous cell carcinoma. Society for Investigative Dermatology, 2011. |
36. Wong, S.J., Winter, K., Meropol, N.J., Anne, R., Kachnic, L.A., Rashid, A., Watson, J.C., Mitchell, E.P., Pollock, J., R. J., Lee, Willett, C. G. Update of results of RTOG 0247: a randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer, 2011 Proceedings of American Society of Clinical Oncology, J Clin Oncol 29: 2011 (May 20 suppl; abstr 3517) |
37. B. A. Murphy, A. Y. Chen, W. J. Curran Jr., A. S. Garden, P. M. Harari, S. J. Wong, L. A. Bellm, M. Schwartz, J. Newman, D. Adkins, D. N. Hayes, U. Parvathaneni, D. Brachman, B. Ghabach, C. Schneider, M. Greenberg, A. Abitbol, P. R. Anne, K. Ang. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Analysis of disparities in care. 2011 Proceedings of American Society of Clinical Oncology, J Clin Oncol 29: 2011 (May 20 suppl; abstr 5533) |
38. 38. Wong S, Malinoski FJ, Botteman M, Corral M, Covello KL, Lange J, Cuyún Carter G, Pennella E, Muehlenbein CE. Head and Neck Cancer US Treatment Patterns and Outcomes in Recurrent and Metastatic Patients, Multidisciplinary Head and Neck Symposium, 2012, Abstr#170. |
39. 39. Johnson A, Tarima S, Wong S, Friedland DR, Runge CL. Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy. Eighth International Conference on Head and Neck Cancer, July 2012 (Oral abstract) |
40. 40. Stuart J. Wong, Theodore Karrison, David N. Hayes, Merril Kies, Martin Edelman, Tawee Tanvetyanon, Athanassios Argiris, Dean Lim, Nabil F Saba, Albiruni R.A. Razak, Francis P. Worden, Heinz-Josef Lenz, Jill Gilbert, John D. Roberts, Everett Vokes, Ezra E.W. Cohen, A Phase II Study of Dasatinib (BMS 354825) in Recurrent or Metastatic ckit-Expressing Adenoid Cystic (ACC) and Non-ACC Malignant Salivary Glands Tumors (MSGT)— NCI 8271. J Clin Oncol 31, 2013 (suppl; abstr 6022) |
